Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future

E-ISSN： 1873-4286|20|32|5127-5138

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.32, 2014-10, pp. : 5127-5138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in treating cognitive impairment in schizophrenia

By Galletly Cherrie

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 259-273

Springer Publishing Company

Access to resources Recommend Favorite

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

By Braff David Light Gregory

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5093-5103

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5104-5114

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3813-3828

Bentham Science Publishers

Access to resources Recommend Favorite